The abstract is read at the publisher; the summary is JClub's.
In adults with cirrhosis at high risk for hepatocellular carcinoma, HelioLiver Dx detected 47.8% of HCC lesions overall and 28.6% of lesions ≤2 cm.
- Why it matters: Ultrasound surveillance has low sensitivity for small HCC nodules and poor adherence, leaving an unmet need for more sensitive, accessible early detection in high-risk patients.
- What they did: In a cross-sectional, prospective, blinded, multicenter validation study (NCT03694600), 1,268 evaluable participants had HelioLiver Dx and ultrasound, with multiphasic MRI as the reference standard.
- The result: HelioLiver Dx showed higher sensitivity than ultrasound (28.3% overall; 0% for lesions ≤2 cm) while maintaining specificity of 87.6% versus 93.9%, meeting prespecified co-primary endpoints.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.